|
Post by brentie on Jun 8, 2015 11:34:55 GMT -5
|
|
|
Post by brentie on Jun 8, 2015 11:39:37 GMT -5
|
|
|
Post by compound26 on Jun 8, 2015 11:59:33 GMT -5
LOL, each Motley Fool article always ends with something like this "As a result, investors with an eye on the long-term may want to stick to the sidelines with this volatile biotech -- at least until Afrezza is showing clear signs of living up to its blockbuster potential". No matter what the price of a particular stock is (or was). In that way, the author can claim that he never makes any mistake because he did not take any position (one way or the other).
|
|
|
Post by ezrasfund on Jun 8, 2015 12:18:38 GMT -5
Headline writer must have had Shake Shack on his mind.
|
|